Skip to content

Clinical trials

Hypertension trials in Indonesia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Country / region: Indonesia Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20072
20111
20121
20171
20192
20211
20222
20234
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status4
Not yet recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Indonesia University3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Sanofi2
Tarumanagara University2
Universitas Airlangga2
A.Menarini Asia-Pacific Holdings Pte Ltd1
Boehringer Ingelheim1
Chatarina Setya Widyastuti1
Chinese University of Hong Kong1
Indonesia Molecule Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension21
Diabetes Mellitus3
Obesity3
Dyslipidemias2
Obesity, Abdominal2
Angina, Stable1
Blindness1
Body Weight1
Cardiovascular Diseases1
Cognitive Dysfunction1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.